A 52-year-old woman from rural Maharashtra presents with progressive dyspnea, palpitations, and a diastolic murmur at the apex. Echocardiography confirms severe mitral stenosis with atrial fibrillation. Regarding the complications and management of mitral stenosis, all of the following are true EXCEPT:

Question

Accepted Answer

C. Surgical commissurotomy or valve replacement is indicated when the mitral valve area falls below 1.0 cm² or symptoms persist despite medical therapy. ## Management and Complications of Mitral Stenosis

**Key Point:** The threshold for intervention in mitral stenosis is a mitral valve area of **≤1.5 cm²** (moderate-to-severe stenosis), NOT 1.0 cm². Intervention is considered when the valve area falls below this threshold AND symptoms are present or the patient is at high risk of complications.

### Mitral Valve Area Classification

| Severity | Valve Area (cm²) | Hemodynamics |
| --- | --- | --- |
| **Normal** | >4.0 | No obstruction |
| **Mild** | 2.5–4.0 | Minimal gradient |
| **Moderate** | 1.5–2.5 | Moderate gradient, symptoms with exertion |
| **Severe** | <1.5 | High gradient, symptoms at rest, pulmonary HTN |
| **Critical** | <1.0 | Severe hemodynamic compromise |

**High-Yield:** Intervention (percutaneous mitral commissurotomy or surgical valve replacement) is indicated when:
1. Mitral valve area **≤1.5 cm²** AND
2. Symptoms present (dyspnea, orthopnea, palpitations) OR
3. Complications develop (pulmonary edema, atrial fibrillation, thromboembolism)

A valve area of 1.0 cm² represents **critical stenosis** — by this point, intervention is already urgently needed. The cutoff for decision-making is 1.5 cm², not 1.0 cm².

### Why Option 2 is Wrong

The statement conflates two concepts:
- **Valve area ≤1.0 cm²** = critical stenosis (already severe, intervention overdue)
- **Decision threshold ≤1.5 cm²** = moderate-to-severe stenosis (when intervention is first considered)

Using 1.0 cm² as the threshold would delay intervention in symptomatic patients with valve areas of 1.0–1.5 cm², exposing them to unnecessary risk of acute pulmonary edema, stroke, or hemodynamic collapse.

### Correct Features (Options 0, 1, 3)

**Option 0 (Correct):** Atrial fibrillation in mitral stenosis creates a low-flow state in the enlarged left atrium → thrombus formation → systemic embolism (especially stroke). Anticoagulation with warfarin (or DOAC if suitable) is standard of care.

**Option 1 (Correct):** Acute pulmonary edema in mitral stenosis is managed by:
- **Diuretics** (reduce pulmonary congestion)
- **Nitrates** (reduce preload and afterload)
- **Beta-blockers or calcium-channel blockers** (slow ventricular rate in AF, reduce cardiac output demand, allow longer diastolic filling time)
- Avoid positive inotropes (increase heart rate and worsen obstruction)

**Option 3 (Correct):** Aortic regurgitation (AR) is a frequent associated lesion in rheumatic mitral stenosis. The combination of MS + AR indicates more extensive rheumatic valve damage and is associated with worse prognosis and earlier need for intervention.

**Clinical Pearl:** In a patient with mitral stenosis and new-onset atrial fibrillation, the priority is rate control (slow the ventricular rate to allow longer diastolic filling across the stenotic valve) and anticoagulation to prevent stroke.

[cite:Harrison 21e Ch 297; Robbins 10e Ch 12]

Answer

A. Anticoagulation with warfarin is indicated because of the high risk of systemic thromboembolism from the fibrillating left atrium

Answer

B. Acute pulmonary edema in mitral stenosis is best managed with diuretics, nitrates, and beta-blockers to slow the ventricular rate

Answer

D. Aortic regurgitation is a common associated lesion in rheumatic mitral stenosis and indicates more severe rheumatic heart disease

Explanation

Practice similar questions